We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Exploiting the Glycome for Cancer Therapeutics

Article   Jun 14, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Exploiting the Glycome for Cancer Therapeutics
 
 
 

RELATED ARTICLES

Exploiting Epigenetics in Cancer Treatment

Article

Changes to the complex of DNA and the proteins that form chromatin are important drivers in many cancers. We explore the challenges and progress in the development of new therapies targeting epigenetic regulators.

READ MORE

Through the Looking Glass of Single Cell Proteomics

Article

To pick apart the differences between individual cells in complex multicellular organisms, we need to look at cells one-by-one. This article takes a look at how several scientists in North America are using single cell proteomics (SCP) technologies to discern disease pathogenesis and enhance directed stem-cell differentiation.

READ MORE

Microfluidic Diagnostic Tools: Could Doctors Soon Be Obsolete?

Article

The world of microfluidics has generated a host of intricate tools on a microscale, ranging from cheap paper-based lateral flow tests to organ-on-a-chip models designed to facilitate personalized diagnostic tests.
This article explores the extent to which microfluidic tools are filling a gap in clinical and point-of-care diagnostics, and touches on how microfluidics could improve the drug discovery process.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE